PUBLISHER: The Business Research Company | PRODUCT CODE: 1811007
PUBLISHER: The Business Research Company | PRODUCT CODE: 1811007
An absorbable powder hemostat is a sterile, bioresorbable material designed to control bleeding during surgical procedures. Made from polysaccharides derived from plants or animals, it quickly absorbs blood and facilitates clot formation. Its powdered form enables easy application to uneven or hard-to-reach areas in surgery. The main purpose of this product is to achieve rapid hemostasis and reduce the risks associated with bleeding during surgery.
The primary categories of absorbable powder hemostats include collagen-based, gelatin-based, cellulose-based, and combination types. Collagen-based powders, sourced from bovine or porcine tissues, help accelerate clotting by activating platelets and are commonly used for effective bleeding control in surgeries. These hemostats come in various forms, including powders, ready-to-use mixes, pre-mixed, and custom formulations, and are distributed through multiple channels such as direct sales, distributors, online platforms, and pharmacies. They are applied in diverse medical fields like surgical procedures, trauma care, orthopedic operations, and cardiovascular surgeries, and are utilized by a range of end-users including hospitals, ambulatory surgical centers, specialty clinics, and outpatient surgery facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The powder absorbable hemostats market research report is one of a series of new reports from The Business Research Company that provides powder absorbable hemostats market statistics, including the powder absorbable hemostats industry global market size, regional shares, competitors with the powder absorbable hemostats market share, detailed powder absorbable hemostats market segments, market trends, opportunities, and any further data you may need to thrive in the powder absorbable hemostats industry. This powder absorbable hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The powder absorbable hemostat market size has grown strongly in recent years. It will grow from $2.30 billion in 2024 to $2.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period was driven by an increase in surgical procedures, expansion of minimally invasive surgeries, heightened awareness of managing surgical bleeding, greater adoption in military and emergency medicine, and a rise in FDA approvals and new product introductions.
The powder absorbable hemostat market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth expected in the forecast period can be linked to the expanding geriatric population, a stronger focus on minimizing surgical complications and reducing procedure times, an increase in outpatient and ambulatory surgeries, development of healthcare infrastructure in emerging markets, and rising investments in bioresorbable and plant-based formulations. Key trends during this period include a move toward biologically sourced and plant-based hemostatic agents, the incorporation of hemostatic powders in robotic and laparoscopic surgeries, broader use beyond hospitals into field and emergency environments, efforts to enhance shelf life and stability at room temperature, and the formation of strategic partnerships and acquisitions.
The growing number of surgeries is expected to drive the expansion of the powder absorbable hemostat market in the coming years. Surgeries involve hands-on or instrument-based medical procedures aimed at treating injuries, illnesses, or enhancing physical function. The increase in surgical procedures is largely due to the rising prevalence of chronic diseases, which often require surgery for effective management. This surge in surgeries boosts the demand for effective bleeding control solutions, thereby increasing the use of powder absorbable hemostats. These hemostats offer fast-acting and precise bleeding control, which is particularly valuable in delicate or minimally invasive surgeries, leading to better patient outcomes. For example, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, 31,057 cosmetic surgeries were performed in the UK in 2022, reflecting a significant 102% increase compared to the previous year. Consequently, the rising number of surgeries is fueling the growth of the powder absorbable hemostat market.
Key players in the powder absorbable hemostat market are focusing on creating advanced products, such as plant-based polysaccharide absorbable hemostat powders, to improve clotting effectiveness and enhance safety during surgeries. This type of hemostatic powder is derived from purified natural starch and works by rapidly absorbing blood to initiate clot formation. It is fully bioresorbable, eliminating the need for removal after use. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT, a starch-based passive absorbable hemostatic powder, in the United States. Designed for patients with intact coagulation systems, PERCLOT controls mild surgical bleeding by quickly absorbing water to form a gelled adhesive matrix that acts as a mechanical barrier, promoting the buildup of platelets, red blood cells, and coagulation proteins. This product adds to Baxter's hemostat offerings by helping reduce blood transfusions and complications, while also lowering overall healthcare costs.
In April 2025, Olympus Canada Inc., a Canadian medical technology provider, formed a partnership with EndoClot Plus, Inc. to enhance gastrointestinal (GI) care through advanced endoscopic solutions. This collaboration aims to expand Olympus' GI product line by delivering cutting-edge hemostatic technologies that improve clinical outcomes in endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) procedures throughout Canada. EndoClot Plus, Inc. is a US-based manufacturer specializing in powder absorbable hemostat systems.
Major players in the powder absorbable hemostat market are Johnson & Johnson, Becton, Dickinson and Company, Baxter International, Integra LifeSciences Corporation, CryoLife Inc., Hangzhou Singclean Medical Products Co. Ltd, Star Alliance, Gelita Medical GmbH, Algan Grup SaglIk Hizmetleri, Ferrosan Medical Devices, Hemostasis LLC, Vascular Solutions Inc., CuraMedical B.V., BioCer Entwicklungs-GmbH, Medcura Inc., Starch Medical Inc., Aegis Lifesciences, Turkish Healthcare, George & George MediSurg Ltd, and Hemostat Medical GmbH.
North America was the largest region in the powder absorbable hemostat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in powder absorbable hemostat report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the powder absorbable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The powder absorbable hemostat market consists of sales of chitosan-based hemostats, kaolin-based hemostats, and oxidized regenerated cellulose (ORC) powders. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Powder Absorbable Hemostat Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on powder absorbable hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for powder absorbable hemostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The powder absorbable hemostat market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.